pyrroles has been researched along with Pyrosis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Deguchi, H; Fernandez, J; Fujimori, I; Igarashi, A; Nakano, H; Oshima, T | 1 |
Armstrong, D; Fass, R; Harris, T; Hunt, B; Leifke, E; Sharma, P; Smith, N; Vaezi, M; Yadlapati, R | 1 |
Araki, T; Ashida, K; Iwakiri, K; Kinoshita, Y; Kudou, K; Miyagi, T; Sakurai, Y; Takabayashi, N | 1 |
Cheng, Y; Dai, Y; Jiang, H; Kou, F; Li, J; Li, X; Liu, J; Lu, Q; Tan, X; Xie, C | 1 |
Ashida, K; Hiramatsu, N; Hori, T; Iwakiri, K; Kudou, K; Nishimura, A; Sakurai, Y; Umegaki, E | 1 |
Arai, E; Fukui, H; Kondo, T; Miwa, H; Oshima, T; Taki, M; Tomita, T; Watari, J | 1 |
Kondo, T; Miwa, H; Oshima, T | 1 |
3 review(s) available for pyrroles and Pyrosis
Article | Year |
---|---|
Network Meta-analysis Comparing Vonoprazan and Proton Pump Inhibitors for Heartburn Symptoms in Erosive Esophagitis.
Topics: Adult; Bayes Theorem; Esophagitis; Gastroesophageal Reflux; Heartburn; Humans; Network Meta-Analysis; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Randomized Controlled Trials as Topic; Sulfonamides; Treatment Outcome | 2022 |
Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.
Topics: Gastroesophageal Reflux; Heartburn; Humans; Proton Pump Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Sulfonamides; Treatment Outcome | 2021 |
Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment.
Topics: Esophageal pH Monitoring; Esophagus; Gastric Acidity Determination; Gastroesophageal Reflux; Heartburn; Humans; Mucous Membrane; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2016 |
4 trial(s) available for pyrroles and Pyrosis
Article | Year |
---|---|
Randomised clinical trial: Efficacy and safety of on-demand vonoprazan versus placebo for non-erosive reflux disease.
Topics: Gastroesophageal Reflux; Heartburn; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2023 |
Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Endoscopy, Gastrointestinal; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Middle Aged; Pyrroles; Sulfonamides; Treatment Outcome | 2019 |
Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole.
Topics: Adult; Aged; Biopsy; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Esophagus; Female; Gastric Mucosa; Gastroesophageal Reflux; Heartburn; Humans; Incidence; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Recurrence; Sulfonamides; Treatment Outcome | 2018 |
Randomised clinical trial: vonoprazan versus lansoprazole for the initial relief of heartburn in patients with erosive oesophagitis.
Topics: Adult; Aged; Double-Blind Method; Esophagitis; Female; Gastroesophageal Reflux; Heartburn; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2019 |